CVS Stock Recent News
CVS LATEST HEADLINES
CVS is a quality BBB S&P credit rated US healthcare convenience “drug store” chain with future growth potential. The price has fallen making it quite an attractive value investment to consider owning with a 11.5% EPS yield.
Dividends are a significant financial commitment, and many companies can't offer them. CVS has rock-solid sales from its pharmacy business, which isn't going anywhere.
Mad Money host Jim Cramer weighs in on various stocks, including First Interstate, CVS and M&T Bank.
Dividend investing happens, whether the stock market is up or down, whether the Fed raises interest rates or lowers. It's all about buying dividend income-producing stocks – the best source of passive income source on your journey to financial freedom.
International Women's Day has come and gone, but as women continue to break barriers in corporate spaces, we would like to highlight just a few of the women CEOs from heavy-hitter companies that we mention often and note how their stock is doing.
Investors are optimistic about CVS Health (CVS), backed by the announcement of entering into a colossal $10.6-billion acquisition agreement to purchase Oak Street Health.
CVS Health has been generating significant sales growth over the years. Its returns haven't been great in the past decade, but the stock could be a market-beating investment in the future.
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health's revenue of $83.8 billion in Q4 2022 reflected a 9.5% y-o-y rise, with growth in all segments.
Liberum has initiated its coverage of CVS Group (AIM:CVSG) PLC with a ‘buy' recommendation and 2,380p. In doing so, it described the group as more of a trusty Labrador than a mythical unicorn (the latter being a $1bn valued tech start-up).